Sponsor Pipeline

Jules Bordet Institute Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
34
Active Trials
20
Recruiting
1
Phase 3
9
Disease Areas
1
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-08-07 NCT02102165
AURORA: Aiming to Understand the Molecular Aberrations in Metastatic Breast Cancer.
Sponsor changed: Breast International Group -> Jules Bordet Institute
New Trial Filings, Last 30 Days
First PostedTrialPhaseStatus
2026-08-10 NCT07753954 Medical Imaging to Re-evaluate Elacestrant Clinical Usage Phase 2 Not Yet Recruiting
2026-08-04 NCT07745205 Holistic Evaluation of Approaches to Long-term Health & Survivorship Active, Not Recruiting
Active Trials by Phase
Phase 3
1
Phase 2
9
Phase 1/2
1
Early Phase 1
1
Not specified
22
Active Trials — top 25 of 34
NCT IDTitleConditionStatus
Phase 3
NCT04019548 Assessment of Swallowing Function and Quality of Life in Oropharyngeal Cancer Patients… Oropharyngeal Cancer Recruiting
Phase 2
NCT06150898 Ketorolac and Pregabalin Effects on breaSt Cancer (KePreSt) Early-stage Breast Cancer Recruiting
NCT06059469 PSMA-PET/CT to Assess the Expression of Specific Membrane Antigen (PSMA) in Patients With… TNBC - Triple-Negative Breast Cancer Recruiting
NCT06595563 HER2 Molecular Imaging With 89Zr-trastuzumab PET/CT as a Predictive Biomarker for… HER2-positive Metastatic Breast Cancer Recruiting
NCT04452032 Prospective Pilot Study Evaluating Dental Side Effects of Radiotherapy on Subjects… Head and Neck Squamous Cell Carcinoma Active, Not Recruiting
NCT03875573 Neo-adjuvant Chemotherapy Combined With Stereotactic Body Radiotherapy to the Primary… Luminal B Active, Not Recruiting
NCT07474558 SCALp Cooling for pReventing aLopecia With nEw anTibody-drug Conjugates Advanced or Metastatic Solid Tumour Not Yet Recruiting
NCT07455331 Flash Radiotherapy for Skin Cancer Cutaneous Squamous Cell Carcinoma (CSCC) Not Yet Recruiting
NCT04503694 Neoadjuvant Regorafenib in Combination With Nivolumab and Short-course Radiotherapy in… Rectal Cancer Stage II Active, Not Recruiting
NCT07753954 Medical Imaging to Re-evaluate Elacestrant Clinical Usage ER+ / HER2- Advanced Breast Cancer Not Yet Recruiting
Phase 1/2
NCT03616886 Paclitaxel + Carboplatin + Durvalumab With or Without Oleclumab for Previously Untreated… Triple Negative Breast Cancer Active, Not Recruiting
Early Phase 1
NCT07143279 Testosterone Supplementation in Patients in Best Supportive Care: Impact on Quality of… Hypotestosteronism Recruiting
Not specified
NCT05502224 Multidisciplinary Approach to Fatigue Breast Cancer Recruiting
NCT06227338 ICG-fluorescence Imaging for Intraoperative Breast Cancer Margins Evaluation: a… Breast Cancer Recruiting
NCT06061874 Ga68-FAPI-46 PET/CT for Preoperative Assessment of Peritoneal Carcinomatosis Cancer Recruiting
NCT06107608 Molecular Imaging of FAP Expressing Cancer-associated Fibroblasts in NSCLC Treated With… Non Small Cell Lung Cancer Recruiting
NCT06867588 The Added-value of PSMA PET in Detecting Clinically Significant Prostate Cancer Lesions… Multiparametric MRI Recruiting
NCT07109440 The Role of the Imaging FAPI PET/CT in Exploring the Microenvironment of Colorectal… Liver Metastases From Colorectal Cancer Recruiting
NCT07119294 Molecular Imaging of Cancer-associated Fibroblasts in Glioblastoma: a FAPI PET/MR Study. Glioblastoma Recruiting
NCT04109131 A Brain Metastases Research Platform to Tackle the Challenge of CNS Metastases in Solid… CNS Metastases Recruiting
NCT07370597 LUtetium-177 DOsimetry as a Predictive Biomarker of Response in Metastatic Prostate… Prostate Cancer (Adenocarcinoma) Recruiting
NCT06925984 Stereotactic Radiotherapy for Oligoprogressive ER+/HER- Metastatic Breast Cancer, a… OligoProgressive Metastatic Disease Recruiting
NCT07451483 Ventral Hernias Following Cytoreductive Surgery : Incidence, Risk Factors and Surgical… Ventral Hernias Recruiting
NCT06523634 Salvage Stereotactic Body Radiotherapy of the Prostate Bed for Biochemical Recurrence… Prostate Cancer Recruiting
NCT07674498 Immune Fitness in Older Patients With Relapsed and Refractory Multiple Myeloma Myeloma Multiple Recruiting
See all 34 active Jules Bordet Institute trials with filters →
Disease Areas
Get alerts when Jules Bordet Institute's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free